Products

Diffucaps® Diltiazem (once-daily)

A A A

Diltiazem is a cardiovascular treatment that uses Eurand's Diffucaps® sustained release technology.


Therapeutic Category Cardiovascular
Indication
  • Hypertension
Available Dosage Strength(s)
  • 120 mg
  • 180 mg
  • 240 mg
  • 300 mg
Product Description
  • Once daily sustained-release capsule
Eurand Technology
Advantages
  • Once daily dosing regimen facilitates patient treatment compliance1
  • Appropriate for use in chronic therapy
  • Protected by issued and pending U.S. and international patents

This information is provided solely for the purpose of the evaluation of business opportunities by potential collaboration partners. The information is based on currently existing data and marketing authorizations in a number of jurisdictions and should not be assumed to be approved by regulatory authorities in any individual country. Consumers should consult with their individual physician for product information and should not rely upon any information provided here.

For more information on this product, please contact us at partners@eurand.com.

1 Kardas P. Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial. J Antimicrob Chemother. 2007;59:531-536.

Cardiovascular Products

More Information

For more information, contact Eurand at partners@eurand.com or +1-267-759-9340

contact Eurand +